Utrecht-based Scinus secures €3 million to tackle one of the biggest challenges in cell therapy
Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
Scinus Group, a Utrecht-based startup that develops and distributes bioreactor technology for stem cell cultivation, has closed a €3 million strategic investment round to accelerate the global rollout of the Osilaris™ cell expansion platform. The round was led by Myosotis Investments. Existing shareholders, including the company’s founders and the Demcon Innovation Fund, also participated in […] The post Utrecht-based Scinus secures €3 million to tackle one of the biggest challenges in cell therapy appeared first on EU-Startups.